GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.830
+0.020 (0.71%)
At close: Nov 26, 2025, 4:00 PM EST
2.800
-0.030 (-1.06%)
After-hours: Nov 26, 2025, 6:59 PM EST
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 10 analysts that cover GoodRx Holdings stock have a consensus rating of "Buy" and an average price target of $5.48, which forecasts a 93.64% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $7.00.
Price Target: $5.48 (+93.64%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GoodRx Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 2 |
| Buy | 6 | 6 | 4 | 4 | 4 | 3 |
| Hold | 4 | 4 | 4 | 4 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +76.68% | Nov 11, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +112.01% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $4.25 → $4 | Hold | Maintains | $4.25 → $4 | +41.34% | Nov 6, 2025 |
| Mizuho | Mizuho | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +41.34% | Nov 6, 2025 |
| UBS | UBS | Hold Maintains $5.25 → $4.25 | Hold | Maintains | $5.25 → $4.25 | +50.18% | Aug 11, 2025 |
Financial Forecast
Revenue This Year
813.91M
from 792.32M
Increased by 2.72%
Revenue Next Year
857.04M
from 813.91M
Increased by 5.30%
EPS This Year
0.38
from 0.04
Increased by 850.92%
EPS Next Year
0.47
from 0.38
Increased by 22.43%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 844.8M | 915.0M | ||||
| Avg | 813.9M | 857.0M | ||||
| Low | 778.1M | 799.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 6.6% | 12.4% | ||||
| Avg | 2.7% | 5.3% | ||||
| Low | -1.8% | -1.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.42 | 0.54 | |||
| Avg | 0.38 | 0.47 | |||
| Low | 0.33 | 0.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 950.0% | 40.8% | |||
| Avg | 850.9% | 22.4% | |||
| Low | 733.0% | 0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.